Gallstones and heavy alcohol use together account for roughly 70% of acute pancreatitis cases. The remaining 30% stem from a mix of high triglycerides, medications, medical procedures, autoimmune conditions, genetic factors, and causes that are never identified. Understanding what triggers the condition starts with what goes wrong inside the pancreas itself.
How the Pancreas Starts Digesting Itself
The pancreas produces powerful digestive enzymes that are supposed to activate only after they reach the small intestine. In acute pancreatitis, those enzymes switch on prematurely, while still inside the pancreas. The key player is trypsinogen, an inactive precursor that gets converted to trypsin. Normally trypsin activates in the gut, where it triggers a cascade that breaks down food. When trypsinogen activates inside pancreatic cells instead, trypsin begins activating other digestive enzymes right there in the tissue.
Research has shown this premature activation happens inside small compartments within the cells where digestive enzymes and cellular cleanup enzymes accidentally mix. A specific cleanup enzyme, cathepsin B, flips the switch on trypsinogen. Once trypsin is loose, it activates the rest of the digestive toolkit, and the pancreas essentially begins digesting itself. This autodigestion triggers intense inflammation, swelling, and in severe cases, tissue death. Every cause of acute pancreatitis ultimately funnels into some version of this process.
Gallstones: The Most Common Trigger
Gallstones cause up to 40% of acute pancreatitis cases in Western countries, making them the single leading cause. The problem occurs when a stone slips out of the gallbladder and travels down through the bile duct system. The bile duct and the pancreatic duct share a common exit point into the small intestine, called the ampulla of Vater. When a stone gets lodged at that junction, it blocks the flow of both bile and pancreatic fluid.
Several things can happen from there. The physical obstruction backs up pancreatic secretions, raising pressure inside the pancreatic duct. Bile may also reflux into the pancreatic duct, where it doesn’t belong. And even stones that pass through the ampulla on their own can cause localized inflammation and swelling at the exit point, temporarily sealing it off. Any of these scenarios creates the conditions for enzymes to activate inside the gland. Gallstone pancreatitis tends to come on suddenly, often after a meal, when the gallbladder contracts to release bile and pushes a stone into the duct system.
Alcohol and Long-Term Damage
Alcohol is the second most common cause, and it typically isn’t triggered by a single night of heavy drinking. Estimates suggest that consuming roughly 10 to 11 standard U.S. drinks per day for at least 6 to 12 years is the threshold for developing symptomatic pancreatitis. That said, not everyone who drinks heavily develops the condition, which suggests individual vulnerability plays a role.
Pancreatic cells can metabolize alcohol directly, and the byproducts cause damage through multiple pathways. One breakdown product, acetaldehyde, interferes with how the cells secrete enzymes and disrupts the internal structures that move substances in and out of cells. Another set of byproducts from a different metabolic pathway directly injure cell membranes. Alcohol metabolism also generates an imbalance between harmful free radicals and the body’s antioxidant defenses, depleting protective compounds and damaging the energy-producing structures within cells. The combined effect sensitizes the pancreas so that a triggering event, even a relatively minor one, can tip the organ into full-blown inflammation.
Very High Triglycerides
Extremely elevated blood triglycerides are a well-established but less common cause. Normal triglyceride levels fall below 150 mg/dL. The risk of triggering pancreatitis climbs sharply once levels exceed 1,000 mg/dL, and some research suggests the threshold may be even higher. One study of 95 patients found none developed pancreatitis when levels stayed below 1,771 mg/dL. In a large population study, people with triglycerides above 500 mg/dL had more than three times the risk of acute pancreatitis compared with those under 150.
The severity of the attack also correlates with how high triglycerides climb. Patients with levels above 1,000 mg/dL experience more local complications and a higher rate of severe disease than those in the 500 to 1,000 range. People with genetic lipid disorders or poorly controlled diabetes are most vulnerable to reaching these dangerous levels, particularly if they also drink alcohol or take certain medications that raise triglycerides.
Medications That Can Trigger Attacks
Drug-induced pancreatitis is uncommon but documented across a surprisingly wide range of medications. The classes most frequently implicated include cholesterol-lowering statins, blood pressure medications known as ACE inhibitors (such as lisinopril and enalapril), estrogen-based hormone therapy, certain diuretics (both loop diuretics and thiazides), HIV antiretroviral therapy, and the seizure medication valproic acid. Immunosuppressants like azathioprine also carry a known risk.
Valproic acid-induced pancreatitis is notable for occurring more often in children. The challenge with drug-induced cases is that the connection can be difficult to identify, since pancreatitis may develop weeks or months after starting a medication. If you’ve had an unexplained episode of pancreatitis, reviewing your medication list with your doctor is a reasonable step.
Medical Procedures
A diagnostic and therapeutic procedure called ERCP, in which a scope is threaded through the mouth and into the bile and pancreatic ducts, is the most common procedural cause. Previous studies have reported post-ERCP pancreatitis rates between 1.6% and 15.7% of procedures, though certain higher-risk populations can see rates above 25%. The procedure can irritate or temporarily obstruct the pancreatic duct opening, triggering inflammation through a mechanism similar to gallstone pancreatitis. Most post-ERCP pancreatitis cases are mild and resolve within a few days.
Smoking as an Independent Risk Factor
Smoking raises the risk of acute pancreatitis independently of alcohol use. A meta-analysis of six studies found that current smokers have a 75% higher risk of developing the condition compared to people who have never smoked. Former smokers still carry a 63% elevated risk. For people who have already had one episode, ever having been a regular smoker increases the chance of a recurrent attack by about 59%. These numbers hold even after accounting for alcohol consumption, confirming that smoking is a standalone risk factor rather than just a marker for heavy drinking.
Genetic Susceptibility
Several gene mutations influence how likely someone is to develop pancreatitis, particularly recurrent or early-onset forms. The first discovered was a mutation in the trypsinogen gene itself, which makes the enzyme more prone to premature activation. This is the basis of hereditary pancreatitis, which tends to run in families and often appears in childhood or adolescence.
Other mutations affect the body’s protective mechanisms. The SPINK1 gene produces a protein that normally inhibits trypsin inside the pancreas, acting as a safety brake. A specific mutation in this gene (p.N34S, common in Western populations) doesn’t necessarily cause a first attack on its own, but it significantly raises the risk of recurrence and may worsen severity, especially in people who also drink heavily. Mutations in the CFTR gene, best known for causing cystic fibrosis, also appear in pancreatitis patients, particularly when they co-occur with SPINK1 variants. The pattern of which mutations matter most varies geographically, with different variants predominating in Asian versus European populations.
Autoimmune Pancreatitis
Autoimmune pancreatitis is a distinct condition where the immune system attacks the pancreas. It comes in two forms. Type 1 involves elevated levels of an antibody called IgG4 in the blood and often affects other organs as well, including lymph nodes, salivary glands, bile ducts, liver, and kidneys. It relapses 30% to 50% of the time after treatment. Type 2 is limited to the pancreas, doesn’t show elevated IgG4, and relapses less than 10% of the time. Autoimmune pancreatitis accounts for a small fraction of all cases but is important to identify because it responds to steroid treatment rather than the supportive care used for other forms.
When No Cause Is Found
Despite thorough workups, about 18% of acute pancreatitis cases are classified as idiopathic, meaning no cause is identified. That proportion has remained surprisingly stable over the years even as diagnostic tools have improved, including advanced imaging and genetic testing. Some of these cases likely involve tiny gallstones (microlithiasis) too small to detect on standard imaging, undiagnosed genetic variants, or subtle anatomical variations in the pancreatic duct system. For people who experience recurrent idiopathic episodes, more specialized testing can sometimes uncover a hidden cause, but a significant number of cases remain unexplained.